SlideShare una empresa de Scribd logo
1 de 22
 Properties can be used to change
manufacturing process (filtration, milling,
drying, etc.) and dissolution rates
 Streamlining the manufacturing process
means less expensive drugs for consumers
millin
g
granula
tion
 Two step process
 1. Nucleation- creation of new phase (i.e. liquid to
solid)
 2. Crystal growth
Crystal
Growth
Saturated
solution
Create
supersaturation and
formation of nuclei
One of the most important means of controlling crystallization
is nucleation
Nucleatio
n
Primary Secondary
(crystal
induced)
Homogen
ous
(spontane
ous)
Heterogene
ous
(foreign
surface)
 Supersaturation  state of solution that
contains more dissolved solute than could
be dissolved under normal circumstances
 Super cooling  process of lowering
temperatures below freezing without
solvent solidifying
 Heterogeneous nucleation  the method
used in our experiments
 Almost all crystallization processes occur
heterogeneously
 What has been done before:
 SAM (self-assembled monolayer)
▪ Inefficient method
hom
het
evaporation
 Biocompatibility
 Easy manufacturing
 Polymeric films contain immiscibility caused
by micelle formation
 Micelles act as nucleation sites for acetaminophen
Drop
crystallization
Cast film
Polymer
solution
Supersaturate
d AAP
PET substrate
 Nucleation mechanism was elucidated by
identifying which crystal face was in contact
with the polymer surface.
 Preferred orientation exhibited in the PXRD
imply preferential nucleation face
(02
2)
AAP Form I ( No Preferred
Orientation)
AAP Form I Preferred Orientation
in the presence of Na CMC film
with SPAN 80
[10-1] [022] Both
Na ALG F108 21% 17% 62%
Na ALG PAA 10% 21% 69%
Na CMC 7% 54% 39%
Na CMC F108 48% 0% 51%
Na CMC SPAN
80
0% 93% 7%
Na
CMC
Na CMC
F108
Na CMC
SPAN80
Na ALG
F108
Na ALG
PAA
Theoretical
C/O Ratio
Experimental
C/O Ratio
Na ALG F108 1~1.09 1.70±0.07
Na ALG PAA 1~1.03 1.94±0.1
Na CMC 1 1.54±0.05
Na CMC F108 1~1.45 2.16±0.12
Na CMC
SPAN 80
1~1.52
(FLAT)
2.67±0.41
(Grey Patch)
4.65±1.59
C/O
Ratio
CMC 1
F108 2-3
SPAN
80
4
ALG 1
PAA 1.5
SPAN 80
Concentration
(g/100g)
[10-1] [022] Both
0.405 0% 100% 0%
0.2025 0% 99% 1%
0.102 0% 93% 7%
0.0506 0% 99% 1%
0.038 0% 98% 2%
0.032 2% 79% 19%
0.018 0% 80% 20%
0.008 0% 76% 24%
0.0054 2% 63% 35%
63
76
80 79
98 99
93
99 100
0
10
20
30
40
50
60
70
80
90
100
0.0054 0.008 0.018 0.032 0.038 0.0506 0.102 0.2025 0.405
ProbabilityofNucleationPlaneat(022)
SPAN Concentration (g/100g)
0
10
20
30
40
50
60
70
80
90
100
0 0.2 0.4 0.6 0.8 1
ProbabilityofNucleationon(022)Face
Concentration of F127 (g/100g)
Probability of Nucleation on (022)
Face
0
10
20
30
40
50
60
70
80
90
100
0 0.01 0.02 0.03 0.04 0.05 0.06
robabilityofNucleationon(022)Face
Concentration of F127 (g/100g)
Probability of Nucleation on (022)
Face
[10-1] [022] Both
0.81 25 24 51
0.05 1 80 19
0.01 3 92 5
0.005 0 94 6
0.001 12 39 49
Probably, there are four phases in F127
controlling nucleation
• Phase 1: after initial addition of small amount
of F127, it starts to lose selectivity
• Phase 2: selectivity begins to increase via the
addition of more F127.
• Phase 3: shows exclusive control of nucleation
within a range
• Phase 4: when the concentration of micelle is
too high, it starts to loose the selectivity.
0.81 0.05 0.01
0.005 0.001
C/O Ratio
0.81 1.91±0.03
0.05 1.40±0.04
0.01 1.48±0.05
0.005 1.36±0.01
0.001 1.33±.0.02
0.81 0.05 0.01
0.005 0.001
 F127 forms globular micelle in size range of 68-
70 nm
 Difficult to see under the microscope
 Size of the micelle formed by F127 and SPAN 80 are
different. Micelle size of F127 is much smaller than
SPAN 80.
 So we rarely can see under microscope.
 F127 and F108 have similar structures, but F127 can
control the nucleation mechanism because F127 has a
lower critical micelle concentration so that F127 can
form micelle at a concentration we can use.
 The ability to form micelles and the number of
micelles that can be formed by the surfactant is
critical to control the nucleation mechanism.
 Methodology for analyzing critical micelle
concentration
 Choose another surfactant to test our
hypothesis
 Supervisor: Dr. Keith Chadwick
 Graduate student: Jing Ling
 Chadwick Lab group
Questions?

Más contenido relacionado

La actualidad más candente

Crystallization by azmin
Crystallization by azminCrystallization by azmin
Crystallization by azminAZMIN MOGAL
 
quality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factorquality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factorSUJIT DAS
 
Case Study on CAPA for Tablet Defects in Pharmaceutical Industry
Case Study on CAPA for Tablet Defects in Pharmaceutical IndustryCase Study on CAPA for Tablet Defects in Pharmaceutical Industry
Case Study on CAPA for Tablet Defects in Pharmaceutical IndustryS S N D Balakrishna Ch
 
Equipments for Pellets
Equipments for PelletsEquipments for Pellets
Equipments for Pelletsbediaman17
 
Crystalisation by asheesh pandey
Crystalisation by asheesh pandeyCrystalisation by asheesh pandey
Crystalisation by asheesh pandeyAsheesh Pandey
 
Pretreatment of water
Pretreatment of waterPretreatment of water
Pretreatment of waterDilip Kumar
 
PRETREATMENT OF WATER
PRETREATMENT OF WATERPRETREATMENT OF WATER
PRETREATMENT OF WATERDilip Kumar
 
Crystallization EASILY DESCRIBED
Crystallization EASILY DESCRIBEDCrystallization EASILY DESCRIBED
Crystallization EASILY DESCRIBEDShikha Popali
 
Melt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationMelt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationSAURABH PATEL
 
Pharmaceutical Engineering: Crystallization
Pharmaceutical Engineering: Crystallization Pharmaceutical Engineering: Crystallization
Pharmaceutical Engineering: Crystallization Parag Jain
 
906162675_411_Comprehensive Final Report
906162675_411_Comprehensive Final Report906162675_411_Comprehensive Final Report
906162675_411_Comprehensive Final ReportCaroline Hallowell
 
Tablet coating defects
Tablet coating defectsTablet coating defects
Tablet coating defectsNIHAAL ROHIT
 
Hot melt extrusion
Hot melt extrusionHot melt extrusion
Hot melt extrusionmanmanasi
 

La actualidad más candente (18)

Crystallization by azmin
Crystallization by azminCrystallization by azmin
Crystallization by azmin
 
quality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factorquality control test for soft gelatin capsule and minim per gram factor
quality control test for soft gelatin capsule and minim per gram factor
 
Case Study on CAPA for Tablet Defects in Pharmaceutical Industry
Case Study on CAPA for Tablet Defects in Pharmaceutical IndustryCase Study on CAPA for Tablet Defects in Pharmaceutical Industry
Case Study on CAPA for Tablet Defects in Pharmaceutical Industry
 
Equipments for Pellets
Equipments for PelletsEquipments for Pellets
Equipments for Pellets
 
SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…
SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…
SEMINAR ON MANUFACTURING AND EVALUATION OF CAPSULES…
 
Crystalisation by asheesh pandey
Crystalisation by asheesh pandeyCrystalisation by asheesh pandey
Crystalisation by asheesh pandey
 
Pretreatment of water
Pretreatment of waterPretreatment of water
Pretreatment of water
 
PRETREATMENT OF WATER
PRETREATMENT OF WATERPRETREATMENT OF WATER
PRETREATMENT OF WATER
 
Crystallization EASILY DESCRIBED
Crystallization EASILY DESCRIBEDCrystallization EASILY DESCRIBED
Crystallization EASILY DESCRIBED
 
IITM-water purifier
IITM-water purifierIITM-water purifier
IITM-water purifier
 
Melt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulationMelt extrusion, a novel technology for granulation
Melt extrusion, a novel technology for granulation
 
Defects in tablet
Defects in tabletDefects in tablet
Defects in tablet
 
Pharmaceutical Engineering: Crystallization
Pharmaceutical Engineering: Crystallization Pharmaceutical Engineering: Crystallization
Pharmaceutical Engineering: Crystallization
 
Crystallization (1)
Crystallization (1)Crystallization (1)
Crystallization (1)
 
906162675_411_Comprehensive Final Report
906162675_411_Comprehensive Final Report906162675_411_Comprehensive Final Report
906162675_411_Comprehensive Final Report
 
Tablet coating defects
Tablet coating defectsTablet coating defects
Tablet coating defects
 
Capsules ppt
 Capsules ppt Capsules ppt
Capsules ppt
 
Hot melt extrusion
Hot melt extrusionHot melt extrusion
Hot melt extrusion
 

Destacado

ATLRUG Announcements - October 2016
ATLRUG Announcements - October 2016ATLRUG Announcements - October 2016
ATLRUG Announcements - October 2016jasnow
 
Etapas de la reingeniería en los negocios
Etapas de la reingeniería en los negociosEtapas de la reingeniería en los negocios
Etapas de la reingeniería en los negociosMariajovanna
 
Machine Learning on dirty data - Dataiku - Forum du GFII 2014
Machine Learning on dirty data - Dataiku - Forum du GFII 2014Machine Learning on dirty data - Dataiku - Forum du GFII 2014
Machine Learning on dirty data - Dataiku - Forum du GFII 2014Le_GFII
 
Use of Licence Exempt Frequency Bands: Draft Report
Use of Licence Exempt Frequency Bands: Draft ReportUse of Licence Exempt Frequency Bands: Draft Report
Use of Licence Exempt Frequency Bands: Draft ReporttechUK
 
Oroca ROV firmware
Oroca ROV firmwareOroca ROV firmware
Oroca ROV firmwareKyung-Wan Ki
 
BIM and trends in construction | Empowering you in a BIM world
BIM and trends in construction | Empowering you in a BIM worldBIM and trends in construction | Empowering you in a BIM world
BIM and trends in construction | Empowering you in a BIM worldThe NBS
 
2012 Motorola Solutions Corporate Overview
2012 Motorola Solutions Corporate Overview2012 Motorola Solutions Corporate Overview
2012 Motorola Solutions Corporate OverviewEric_Freeburg
 
2016 conservation track: a climate change vulnerability framework and intera...
2016 conservation track:  a climate change vulnerability framework and intera...2016 conservation track:  a climate change vulnerability framework and intera...
2016 conservation track: a climate change vulnerability framework and intera...GIS in the Rockies
 
2016 asprs track: spatial analysis at the continental scale: a practical app...
2016 asprs track:  spatial analysis at the continental scale: a practical app...2016 asprs track:  spatial analysis at the continental scale: a practical app...
2016 asprs track: spatial analysis at the continental scale: a practical app...GIS in the Rockies
 
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...Future use of millimetre waves – outcome of WRC-15 and study priorities for W...
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...techUK
 
Novel drug delivery systems
Novel drug delivery systemsNovel drug delivery systems
Novel drug delivery systemsPatel maulik
 

Destacado (14)

ATLRUG Announcements - October 2016
ATLRUG Announcements - October 2016ATLRUG Announcements - October 2016
ATLRUG Announcements - October 2016
 
Etapas de la reingeniería en los negocios
Etapas de la reingeniería en los negociosEtapas de la reingeniería en los negocios
Etapas de la reingeniería en los negocios
 
Machine Learning on dirty data - Dataiku - Forum du GFII 2014
Machine Learning on dirty data - Dataiku - Forum du GFII 2014Machine Learning on dirty data - Dataiku - Forum du GFII 2014
Machine Learning on dirty data - Dataiku - Forum du GFII 2014
 
EPPING RANCH
EPPING RANCHEPPING RANCH
EPPING RANCH
 
Use of Licence Exempt Frequency Bands: Draft Report
Use of Licence Exempt Frequency Bands: Draft ReportUse of Licence Exempt Frequency Bands: Draft Report
Use of Licence Exempt Frequency Bands: Draft Report
 
Oroca ROV firmware
Oroca ROV firmwareOroca ROV firmware
Oroca ROV firmware
 
아슬하다
아슬하다아슬하다
아슬하다
 
BIM and trends in construction | Empowering you in a BIM world
BIM and trends in construction | Empowering you in a BIM worldBIM and trends in construction | Empowering you in a BIM world
BIM and trends in construction | Empowering you in a BIM world
 
2012 Motorola Solutions Corporate Overview
2012 Motorola Solutions Corporate Overview2012 Motorola Solutions Corporate Overview
2012 Motorola Solutions Corporate Overview
 
2016 conservation track: a climate change vulnerability framework and intera...
2016 conservation track:  a climate change vulnerability framework and intera...2016 conservation track:  a climate change vulnerability framework and intera...
2016 conservation track: a climate change vulnerability framework and intera...
 
2016 asprs track: spatial analysis at the continental scale: a practical app...
2016 asprs track:  spatial analysis at the continental scale: a practical app...2016 asprs track:  spatial analysis at the continental scale: a practical app...
2016 asprs track: spatial analysis at the continental scale: a practical app...
 
Visual Resume
Visual ResumeVisual Resume
Visual Resume
 
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...Future use of millimetre waves – outcome of WRC-15 and study priorities for W...
Future use of millimetre waves – outcome of WRC-15 and study priorities for W...
 
Novel drug delivery systems
Novel drug delivery systemsNovel drug delivery systems
Novel drug delivery systems
 

Similar a Controlling Crystallization of Acetaminophen via Polymeric Films and Surfactants

47805741 crystallization-whole-broth-processing
47805741 crystallization-whole-broth-processing47805741 crystallization-whole-broth-processing
47805741 crystallization-whole-broth-processing78686
 
Fibic thermoplastic cellulose final public seminar 15 4 2014
Fibic thermoplastic cellulose final public seminar 15 4 2014Fibic thermoplastic cellulose final public seminar 15 4 2014
Fibic thermoplastic cellulose final public seminar 15 4 2014Fubio
 
Research Presentation
Research PresentationResearch Presentation
Research PresentationJennifer La
 
Catalyst preparation methods
Catalyst preparation methodsCatalyst preparation methods
Catalyst preparation methods9495094029
 
Nano particles synthesis
Nano particles synthesisNano particles synthesis
Nano particles synthesisinamchemist
 
Plasma Waste Vitrification
Plasma Waste VitrificationPlasma Waste Vitrification
Plasma Waste VitrificationJessica Smith
 
Wheat germ pre final
Wheat germ pre finalWheat germ pre final
Wheat germ pre finalnatapple
 
Purification optimization and characterization of protease from Bacillus va...
Purification optimization and characterization of  protease from  Bacillus va...Purification optimization and characterization of  protease from  Bacillus va...
Purification optimization and characterization of protease from Bacillus va...Vaibhav Maurya
 
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...SAJJAD KHUDHUR ABBAS
 
Safety of oocyte cryopreservation lessons from donor banking alpha-nagy_pete...
Safety of oocyte cryopreservation  lessons from donor banking alpha-nagy_pete...Safety of oocyte cryopreservation  lessons from donor banking alpha-nagy_pete...
Safety of oocyte cryopreservation lessons from donor banking alpha-nagy_pete...Merck KGaA, Darmstadt, Germany
 
Downstream processing
Downstream processingDownstream processing
Downstream processingRamaJumwal2
 
140916_PDA_Europe_Contr_Nucl_Searles
140916_PDA_Europe_Contr_Nucl_Searles140916_PDA_Europe_Contr_Nucl_Searles
140916_PDA_Europe_Contr_Nucl_SearlesJim Searles
 
IOGPT Presentation.pptx
IOGPT Presentation.pptxIOGPT Presentation.pptx
IOGPT Presentation.pptxAnikaPandey8
 
Impact of processing parameters on production of sub-100 nm drug particles - ...
Impact of processing parameters on production of sub-100 nm drug particles - ...Impact of processing parameters on production of sub-100 nm drug particles - ...
Impact of processing parameters on production of sub-100 nm drug particles - ...Kihyun Kim
 

Similar a Controlling Crystallization of Acetaminophen via Polymeric Films and Surfactants (20)

47805741 crystallization-whole-broth-processing
47805741 crystallization-whole-broth-processing47805741 crystallization-whole-broth-processing
47805741 crystallization-whole-broth-processing
 
Fibic thermoplastic cellulose final public seminar 15 4 2014
Fibic thermoplastic cellulose final public seminar 15 4 2014Fibic thermoplastic cellulose final public seminar 15 4 2014
Fibic thermoplastic cellulose final public seminar 15 4 2014
 
adfb[oadf
adfb[oadfadfb[oadf
adfb[oadf
 
Research Presentation
Research PresentationResearch Presentation
Research Presentation
 
Catalyst preparation methods
Catalyst preparation methodsCatalyst preparation methods
Catalyst preparation methods
 
Nano particles synthesis
Nano particles synthesisNano particles synthesis
Nano particles synthesis
 
Plasma Waste Vitrification
Plasma Waste VitrificationPlasma Waste Vitrification
Plasma Waste Vitrification
 
ACE Poster
ACE PosterACE Poster
ACE Poster
 
ISOTECH SilkyLube
ISOTECH SilkyLubeISOTECH SilkyLube
ISOTECH SilkyLube
 
Coagulation flocculation and_precipitation
Coagulation flocculation and_precipitationCoagulation flocculation and_precipitation
Coagulation flocculation and_precipitation
 
Wheat germ pre final
Wheat germ pre finalWheat germ pre final
Wheat germ pre final
 
Purification optimization and characterization of protease from Bacillus va...
Purification optimization and characterization of  protease from  Bacillus va...Purification optimization and characterization of  protease from  Bacillus va...
Purification optimization and characterization of protease from Bacillus va...
 
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...
Sustainable Approach Of Recycling Palm Oil Mill Effluent Using Integrated Bio...
 
Safety of oocyte cryopreservation lessons from donor banking alpha-nagy_pete...
Safety of oocyte cryopreservation  lessons from donor banking alpha-nagy_pete...Safety of oocyte cryopreservation  lessons from donor banking alpha-nagy_pete...
Safety of oocyte cryopreservation lessons from donor banking alpha-nagy_pete...
 
Downstream processing
Downstream processingDownstream processing
Downstream processing
 
Kelechukwu et al
Kelechukwu et alKelechukwu et al
Kelechukwu et al
 
Frother type Impact over size by size Cu recovery
Frother type Impact over size by size Cu recoveryFrother type Impact over size by size Cu recovery
Frother type Impact over size by size Cu recovery
 
140916_PDA_Europe_Contr_Nucl_Searles
140916_PDA_Europe_Contr_Nucl_Searles140916_PDA_Europe_Contr_Nucl_Searles
140916_PDA_Europe_Contr_Nucl_Searles
 
IOGPT Presentation.pptx
IOGPT Presentation.pptxIOGPT Presentation.pptx
IOGPT Presentation.pptx
 
Impact of processing parameters on production of sub-100 nm drug particles - ...
Impact of processing parameters on production of sub-100 nm drug particles - ...Impact of processing parameters on production of sub-100 nm drug particles - ...
Impact of processing parameters on production of sub-100 nm drug particles - ...
 

Controlling Crystallization of Acetaminophen via Polymeric Films and Surfactants

  • 1.
  • 2.  Properties can be used to change manufacturing process (filtration, milling, drying, etc.) and dissolution rates  Streamlining the manufacturing process means less expensive drugs for consumers millin g granula tion
  • 3.  Two step process  1. Nucleation- creation of new phase (i.e. liquid to solid)  2. Crystal growth Crystal Growth Saturated solution Create supersaturation and formation of nuclei One of the most important means of controlling crystallization is nucleation
  • 5.  Supersaturation  state of solution that contains more dissolved solute than could be dissolved under normal circumstances  Super cooling  process of lowering temperatures below freezing without solvent solidifying  Heterogeneous nucleation  the method used in our experiments
  • 6.  Almost all crystallization processes occur heterogeneously  What has been done before:  SAM (self-assembled monolayer) ▪ Inefficient method hom het evaporation
  • 7.  Biocompatibility  Easy manufacturing  Polymeric films contain immiscibility caused by micelle formation  Micelles act as nucleation sites for acetaminophen
  • 9.  Nucleation mechanism was elucidated by identifying which crystal face was in contact with the polymer surface.  Preferred orientation exhibited in the PXRD imply preferential nucleation face (02 2) AAP Form I ( No Preferred Orientation) AAP Form I Preferred Orientation in the presence of Na CMC film with SPAN 80
  • 10. [10-1] [022] Both Na ALG F108 21% 17% 62% Na ALG PAA 10% 21% 69% Na CMC 7% 54% 39% Na CMC F108 48% 0% 51% Na CMC SPAN 80 0% 93% 7%
  • 11. Na CMC Na CMC F108 Na CMC SPAN80 Na ALG F108 Na ALG PAA
  • 12. Theoretical C/O Ratio Experimental C/O Ratio Na ALG F108 1~1.09 1.70±0.07 Na ALG PAA 1~1.03 1.94±0.1 Na CMC 1 1.54±0.05 Na CMC F108 1~1.45 2.16±0.12 Na CMC SPAN 80 1~1.52 (FLAT) 2.67±0.41 (Grey Patch) 4.65±1.59 C/O Ratio CMC 1 F108 2-3 SPAN 80 4 ALG 1 PAA 1.5
  • 13. SPAN 80 Concentration (g/100g) [10-1] [022] Both 0.405 0% 100% 0% 0.2025 0% 99% 1% 0.102 0% 93% 7% 0.0506 0% 99% 1% 0.038 0% 98% 2% 0.032 2% 79% 19% 0.018 0% 80% 20% 0.008 0% 76% 24% 0.0054 2% 63% 35% 63 76 80 79 98 99 93 99 100 0 10 20 30 40 50 60 70 80 90 100 0.0054 0.008 0.018 0.032 0.038 0.0506 0.102 0.2025 0.405 ProbabilityofNucleationPlaneat(022) SPAN Concentration (g/100g)
  • 14. 0 10 20 30 40 50 60 70 80 90 100 0 0.2 0.4 0.6 0.8 1 ProbabilityofNucleationon(022)Face Concentration of F127 (g/100g) Probability of Nucleation on (022) Face 0 10 20 30 40 50 60 70 80 90 100 0 0.01 0.02 0.03 0.04 0.05 0.06 robabilityofNucleationon(022)Face Concentration of F127 (g/100g) Probability of Nucleation on (022) Face [10-1] [022] Both 0.81 25 24 51 0.05 1 80 19 0.01 3 92 5 0.005 0 94 6 0.001 12 39 49 Probably, there are four phases in F127 controlling nucleation • Phase 1: after initial addition of small amount of F127, it starts to lose selectivity • Phase 2: selectivity begins to increase via the addition of more F127. • Phase 3: shows exclusive control of nucleation within a range • Phase 4: when the concentration of micelle is too high, it starts to loose the selectivity.
  • 16. C/O Ratio 0.81 1.91±0.03 0.05 1.40±0.04 0.01 1.48±0.05 0.005 1.36±0.01 0.001 1.33±.0.02
  • 18.  F127 forms globular micelle in size range of 68- 70 nm  Difficult to see under the microscope
  • 19.  Size of the micelle formed by F127 and SPAN 80 are different. Micelle size of F127 is much smaller than SPAN 80.  So we rarely can see under microscope.  F127 and F108 have similar structures, but F127 can control the nucleation mechanism because F127 has a lower critical micelle concentration so that F127 can form micelle at a concentration we can use.  The ability to form micelles and the number of micelles that can be formed by the surfactant is critical to control the nucleation mechanism.
  • 20.  Methodology for analyzing critical micelle concentration  Choose another surfactant to test our hypothesis
  • 21.  Supervisor: Dr. Keith Chadwick  Graduate student: Jing Ling  Chadwick Lab group

Notas del editor

  1. First, I will introduce the importance of crystallization. Crystallization, as you can see from the flow chart, is the first step in the manufacturing process and It is the most important unit operation for separation and purification. This is because crystallization determines the properties of the crystal such as—purity, size and shape distribution. Theses properties, in turn, can affect the downstream processing procedures—like filtration/drying, milling, blending, etc. etc. Therefore, finding a way to control crystallization can lead to a more streamlined and efficient manufacturing process, which ultimately means more inexpensive drugs for consumers.
  2. The crystallization process consists of two major events—nucleation and crystal growth. The first stage in crystal formation is nucleation. Nucleation is a change in state that occurs around certain focal points i.e. nuclei And crystal growth is essentially the growth of the nuclei. Both of these events affect the size and shapes of the crystals obtained. Therefore one of the most important means of controlling crystallization is nucleation.
  3. The nucleation process can be classified as either primary or secondary. Secondary nucleation requires seed crystals or existing crystals to induce crystal growth whereas that primary nucleation happens spontaneously without the presence of pre-existing crystals. Under primary there is heterogeneous and homogeneous nucleation. Heterogeneous nucleation occurs when crystal growth happens on a foreign surface like for example dust particles or the sides of the container and homogeneous nucleation, which is much more rare than heterogeneous nucleation because it occurs without the presence or influence of foreign surfaces.
  4. There are several methods to control nucleation. One of which is supersaturation Another is super cooling, which is the process of lowering the temperature below freezing while still having the solvent remain a liquid, the solvent can then be induced to crystal with the addition of a seed crystal, which acts as the nucleus People have also used probes to detect crystal size and by detecting for uniform crystal size, they can know how to change the parameters (cooling rate or temperature, etc.) to get uniform crystal size And also, heterogeneous nucleation, which is the method our experiment uses to control nucleation
  5. Almost all crystallization processes occur heterogeneously. This is due to the fact that they are more thermodynamically favored than homogeneous nucleation. The surfaces or impurities that nucleation occurs on acts to lower the activation energy for nucleation below that of homogeneous nucleation. A method that has been used before to control crystal nucleation is SAM or self-assembled monolayers. In this method a metal substrate having areas of different nucleating properties, pictured by the blue dots and then are immersed in a solvent and allowed to evaporate. As you can imagine taking the time to make each individual island can very inefficient.
  6. Which is why I will introduce the advantages to using our method. Firstly, it is biocompatible, with the self-assembled monolayers they often used metals substrates in their procedure which is, obviously, not digestible by people and also not approved by the FDA. It’s also easier to manufacture, unlike with the self-assembled monolayers where you have to take the time to make each individual island (or nucleation site) on the substrate with our method all you have to do is the cast a film. And lastly, the polymeric films contain immiscibility generated by micelle formation, and the micelles, similarly to sam’s islands will act as nucleation sites
  7. The methodology to creating the polymeric films is very simple. You first start out by pouring the polymer solution onto the substrate where you then drag the film caster (pictured here) across the substrate to ensure that the film has a uniform thickness and then you allow it air dry. Once dried, you dropped a supersaturated solution of acetaminophen on the film and allowed it to air dry before Jing x-rayed the samples.
  8. PXRD acronym?  powder xray diffraction Nucleation mechanism is defined by which crystal face is nucleated on the polymer surface. We found that AAP form I: powder showed no preferred orientation and we can see that because there are multiple peaks of similar intensity. However, we add Na CMC (sodium carboxymethyl cellulose) and the surfactant, span 80 we can see the there is a strong peak indicating preferred orientation towards the 022 face Preferred orientation is the way to find out which face nucleates on the surface (how we study nucleation mechanism)  arises when crystals have a stronger tendency to be oriented a certain way, or ways, than all other ways.
  9. PET (Poly ester) Na CMC, Na CMC F108, Na CMC span 80, Na alginate with F108 and Na alginate with PAA (or poly acrylic acid)) While 4 out of the 5 films showed little to moderate probability to nucleate on the 022 face, the film containing the surfactant span 80 showed a 93% probability to nucleate on 022 face BOTH: two peaks then the ratio to one another is less than 2 then we say that they are both preferred Have two peaks, if the peaks ratio to one another is greater than 2 then we say it prefers to nucleate on one face
  10. When looking at the surface chemistry of the films we can see that 4 out of the 5 films exhibit uniform surface chemistry while span 80 has these grey bumps, which we are the micelles
  11. By looking at the c/o ratios of the surfactants we see that span 80 has the highest ratio, while the other surfactants have a low ratio. Furthermore, the grey patches/bumps (which are the surfactant rich areas) have a high c/o ratio than the flat areas
  12. From this data we can see that the higher the concentration of span 80 the greater probability to nucleate on the 022 face Also, we can see that you have to be above a certain range in order to achieve complete selectivity
  13. Another surfactant we analyzed was F127. From our experiment we think that there are four phases in F127 controlling nucleation Phase 1: Phase 1 shows that after a small addition of F127, selectivity is decreased Phase 2: Phase 2 shows that the selectivity is increasing by the addition of more F127, but the number of micelles is still not enough for complete control of nucleation Phase 3: The 3rd phase shows exclusive control of nucleation within a certain range, possibly meaning that the number of micelles has reached the optimum level to control nucleation Phase 4: This phase shows (as shown by the tail end of this graph), that when the number of micelles is too high, selectivity gets lost
  14. (SEM) Scanning electron microscope These images show the surface of the F127 film at 5 different concentrations to be uniform and without bumps—which is very different compared to when we looked at the surface of span 80
  15. EDS acronym (same as EDX) This chart shows a direct relationship between the concentration of F127 and C/O ratio. As we decreased the amount of F127 the C/O ratio decreased.
  16. These are microscope images of the varying concentrations of F127 polymer solution and as you can see there are no micelles visible, even at high concentrations of F127.
  17. And this is because the micelles that F127 form are very small and is difficult to see under the microscope. Whereas with Span 80, the micelles are clearly visible and that is because the micelles of span 80 are in the micrometer range while f127 is nanometer range CMC of F127 is higher so you need to add more of it to see micelles whereas CMC of span 80 is lower so you need to add less surfactant
  18. Firstly, the size of the micelles formed by f127 is much smaller than that of span80, which makes the micelles hard to see under a microscope. Secondly, F127 and F108 have similar structures, but F127 can control nucleation mechanism because it has a lower critical micelle concentration, meaning it can form micelles at the concentrations that we study Lastly, the ability to form micelles and the number of micelles that can be formed by the surfactant are both critical to control the nucleation mechanism
  19. Some areas of future work include finding another method for analyzing the critical micelle concentration and choosing another surfactant to test to see whether or not our hypothesis is consistent.